MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway

Life Sciences
Megumi HiraokaMasayuki Yoshida

Abstract

Monocyte-endothelial interaction plays a pivotal role in atherosclerosis. We previously showed that HMG CoA reductase inhibitor reduces adhesion, however, not the rolling of monocytes to vascular endothelium under flow in vitro. In the present study, we investigated the effect of pitavastatin, a novel HMG CoA reductase inhibitor, on the transition from monocyte rolling on vascular endothelium to stable adhesion induced by MCP-1 under flow (shear stress = 1.0 dyne/cm(2)). Control THP-1 cells rolled on activated (IL-1beta, 4 hours) human umbilical vein endothelial cells (HUVEC) and the number of adhered THP-1 cells were significantly enhanced following the addition of 50 nM of MCP-1 (p < 0.002). In contrast, MCP-1 failed to convert pitavastatin-treated (10 microM, 48 hours) THP-1 rolling to stable adhesion, as compared to baseline adhesion, prior to the addition of MCP-1 (p > 0.4). Pitavastatin-induced changes in THP-1 cells were reversed by treatment with 10 microM of mevalonate, the intermediate of cholesterol biosynthesis. To elucidate the mechanism by which pitavastatin modulates MCP-1-induced THP-1 adhesive interactions, the possible involvement of extracellular signal-regulated kinase 1/2 (ERK1/2) was examined. Western blot...Continue Reading

References

Mar 30, 2001·The Journal of Biological Chemistry·N AshidaT Kita

❮ Previous
Next ❯

Citations

Mar 1, 2011·Therapeutic Advances in Chronic Disease·Leiv Ose
Apr 6, 2006·Biological & Pharmaceutical Bulletin·Juyong WangIsao Kitajima
Nov 28, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Katsumi MiyauchiMasunori Matsuzaki
Mar 31, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Pedro Marques da Silva
Jan 26, 2010·Biochemical and Biophysical Research Communications·Jia LiLan-Feng Wang
Jul 24, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hedwich F Kuipers, Peter J van den Elsen
Sep 14, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yoshihiro KamadaTetsuo Takehara
Oct 12, 2007·Expert Opinion on Pharmacotherapy·Toshio HayashiAkihisa Iguchi
Nov 5, 2008·Journal of Atherosclerosis and Thrombosis·Tadashi YamakawaYasuo Terauchi
Jul 16, 2011·Biochemical and Biophysical Research Communications·Shih-Yi ChuangJong-Hwei S Pang
Sep 12, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Sunny LimKi Hoon Han
Sep 20, 2007·The Journal of Pharmacology and Experimental Therapeutics·Chiari KojimaMasayuki Yoshida
Nov 30, 2018·Expert Opinion on Pharmacotherapy·Paul ChanZhong-Min Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.